Results 221 to 230 of about 337,094 (289)

Intramuscular pH monitoring before and during exercise in individuals with intermittent claudication compared to healthy controls: A feasibility study. [PDF]

Sci Prog
Ablett AD, Collins P, Ball D, Brittenden J, Johnstone AJ.   +4 more
europepmc   +1 more source

Evaluation of the implementation of personalised outcomes forecasts to optimise supervised exercise therapy in patients with intermittent claudication: a multimethods process evaluation. [PDF]

BMJ Open Qual
Marcellis LHM, Sinnige A, van Bergen AGE, Spruijt S, Kittelson A, Teijink JAW, van der Wees PJ, Hoogeboom TJ.   +7 more
europepmc   +1 more source

Cancer Risk and Subsequent Survival after Hospitalization for Intermittent Claudication

Cancer Epidemiology, Biomarkers and Prevention, 2015
T. Onega, J. Baron, S. Johnsen, L. Pedersen, D. Farkas, H. Sørensen   +5 more
semanticscholar   +1 more source

Intermittent claudication [PDF]

, 2020
openaire   +1 more source

A systematic review of treatment of intermittent claudication in the lower extremities.

Journal of Vascular Surgery, 2015
R. Malgor, Fares Alahdab, Tarig A. Elraiyah, Adnan Z. Rizvi, Melanie A. Lane, L. Prokop, O. Phung, W. Farah, V. Montori, M. Conte, M. Murad   +10 more
semanticscholar   +1 more source

Behaviour change interventions to promote physical activity in people with intermittent claudication: the OPTIMA systematic review.

Health Technol Assess
Abaraogu UO, Dall P, Seenan C, Rhodes S, Gorely T, McParland J, Brittenden J, Anieto EM, Booth L, Gormal C, Dearling J, Fenton C, Audsley S, Fairer K, Bearne L, Skelton DA.   +15 more
europepmc   +1 more source

Reported outcomes in studies of intermittent claudication - first step toward a core outcome set: systematic review. [PDF]

BJS Open
Shwan A, Lamidi S, Chan C, Daniels E, Song-Smith C, Hanna L, Sounderajah V, Houghton JSM, Sayers RD.   +8 more
europepmc   +1 more source

Intermittent claudication. [PDF]

BMJ, 1968
openaire   +2 more sources

Intermittent Claudication Services in England: Insights from a Freedom of Information Request

Lampridou S, Saghdaoui LB, Boobier C, Judah G, Wells M, Davies AH.   +5 more
europepmc   +1 more source

ADVERSE DRUG EVENTS ASSOCIATED WITH CILOSTAZOL ADMINISTRATION IN PATIENTS WITH INTERMITTENT CLAUDICATION: A DISPROPORTIONALITY ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS)

Roaa Naser AlShajrawi, Omar Hamdan, Yousef Al-Mabrouk, Qais Mussa, Ahmad Alsawalmeh   +4 more
openalex   +1 more source